First-in-Class Humanized Antibody against Alternatively Spliced Tissue Factor Augments Anti-Metastatic Efficacy of Chemotherapy in a Preclinical Model of Pancreatic Ductal Adenocarcinoma
针对选择性剪接组织因子的首创人源化抗体增强了胰腺导管腺癌临床前模型中化疗的抗转移功效
期刊:International Journal of Molecular Sciences
影响因子:0.7
doi:10.3390/ijms25052580
Clayton S Lewis, Charles Backman, Sabahat Ahsan, Ashley Cliff, Arthi Hariharan, Jen Jen Yeh, Xiang Zhang, Changchun Xie, Davendra P S Sohal, Vladimir Y Bogdanov
